http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016000935-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c805e74cf7422cf3d47460c3ef44a2d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90f6e4743d78d41c5c22822954fd0c6f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0075 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
| filingDate | 2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c24dfe02e673b3f852b1a21a2a741423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0eb94b940499cb7239e60e90ea2bcd7 |
| publicationDate | 2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2016000935-A1 |
| titleOfInvention | Increasing tumor oxygenation for diagnostic assessments |
| abstract | A method of assessing the susceptibility of a tumor to reduction in hypoxia, comprising delivering oxygen and CO 2 to attain a starting end tidal concentration of oxygen (PetO 2 ) between 350 and 450 mm Hg, and a starting end tidal concentration of CO 2 (PetCO 2 ) between 42 and 55 mm Hg; changing PetO 2 and/or PetCO 2 , wherein at least one increment of change is maintained for a time sufficient to obtain a surrogate measure of tumor oxygenation reflecting change in tumor oxygenation relative to a previously measured surrogate value of tumor oxygenation, wherein the starting PetO 2 and/or an incremental change in PetO 2 is approximately between 375 and 425 mm Hg, and wherein the starting PetCO 2 and/or an incremental change in PetCO 2 is approximately between 42 and 50 mm Hg; and obtaining a surrogate measure of tumor oxygenation after changing PetO 2 and/or PetCO 2 for comparison to a previously measured surrogate value of tumor oxygenation. |
| priorityDate | 2014-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.